Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.47 |
| ▸ | CA9 | Q16790 | 3/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.41 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.41 |
| ▸ | BMX | P51813 | 1/20 | 0.40 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 5/20 | 0.39 |
| ▸ | PPARA | Q07869 | 5/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25740891 | 0.98 | CA12 (0.45) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL25098590 | 0.91 | CA12 (0.54) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL6374305 | 0.91 | CA12 (0.54) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL17550872 | 0.89 | CA12 (0.51) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL29597362 | 0.89 | CA12 (0.56) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL21905500 | 0.89 | CA12 (0.56) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL14270741 | 0.88 | CA12 (0.51) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL7593430 | 0.88 | CA12 (0.51) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL14188157 | 0.88 | CA12 (0.51) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL14490059 | 0.88 | CA12 (0.51) | CA12CA1CA2CA9HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10756277-B2 | Organic compound and organic electroluminescent device comprising the same | DOOSAN SOLUS CO., LTD. (KR) | 2020-08-25 | — | — | US | disclosed |
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | DOOSAN CORPORATION (KR) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | OR10J3, ORC3, L1CAM | CA12 1302/4885CA1 2335/4885CA2 1794/4885 |
| US-10756277-B2 | Organic compound and organic electroluminescent device comprising the same | OR10J3, L1CAM, ICOSLG | CA12 2032/4885CA1 3432/4885CA2 2740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.